SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO LTD has a total of 13 patent applications. It decreased the IP activity by 87.0%. Its first patent ever was published in 2014. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are UNIV CHANG GUNG SCIENCE & TECHNOLOGY, BIOTA SCIENT MANAGEMENT and NANJING TRANSTHERA BIOSCIENCES CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Dong Jiaqiang | 9 |
#2 | Dong Ping | 7 |
#3 | Cai Dongmei | 7 |
#4 | Zhu Jiuxiang | 7 |
#5 | Hu Yonghan | 7 |
#6 | Wang Tie-Lin | 7 |
#7 | Li Manhua | 4 |
#8 | Chen Shuhui | 2 |
#9 | Lu Jianyu | 2 |
#10 | He Huijun | 2 |
Publication | Filing date | Title |
---|---|---|
CN110139863A | Indoles and substituted piperidines as estrogen receptor degradation agent | |
CN106316979A | Acotiamide hydrochloride preparation method | |
CN106317060A | Preparation method of conivaptan hydrochloride | |
CN106317150A | Crystalline compound for antitumor medicines and method for preparing crystalline compound | |
CN104042566A | Ibuprofen composition injection and preparation method thereof |